
    
      This study is a phase 2/3, double-blinded, randomized controlled trial (RCT) in which 80
      adults with TRD being treated with an approved antidepressant medication will be assigned to
      either FMT capsules or identically appearing placebo capsules. Participant will be followed
      for f for 14 weeks post FMT. This extended observation period will allow us to see, whether
      FMT leads to sustainable improvements in depression and changes in intestinal microbiome
    
  